12/19/2024 6:38 AM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 3:15 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024 6:07 AM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2024 3:15 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) House David Duane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 3:15 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2024 3:33 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/26/2024 6:50 AM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 3:15 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) House David Duane (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 4:00 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 3:20 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 3:15 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ARMP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
06/28/2024 5:12 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Kyme Pierre (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/07/2024 3:25 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024 7:00 AM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 3:20 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/21/2024 3:15 PM | Armata Pharmaceuticals, Inc. (Filer) Armata Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 7:00 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Birx Deborah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:00 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Odysseas Kostas D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:01 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Haimovitz Jules (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:02 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Schlesinger Sarah J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:02 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Rychlik Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:03 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Peterson Todd C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:03 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:05 PM | Armata Pharmaceuticals, Inc. (Issuer) Armata Pharmaceuticals (Issuer) PATTI JOSEPH M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:35 PM | Armata Pharmaceuticals, Inc. (Subject) Armata Pharmaceuticals (Subject) Innoviva, Inc. (Filed by)
| Form SC 13D/A | |